This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Oregon Health & Science University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Elie Traer: Innovator in Acute Myeloid Leukemia Treatments
Introduction
Elie Traer is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of medicine, particularly in the treatment of acute myeloid leukemia (AML). His work focuses on developing methods to treat this serious condition, especially in patients with gene mutations.
Latest Patents
Elie Traer holds a patent for his invention titled "Treatments for mutations in acute myeloid leukemia." This patent outlines useful methods for treating AML in humans who present with gene mutations. His innovative approach aims to improve the outcomes for patients suffering from this challenging disease.
Career Highlights
Traer is affiliated with Oregon Health & Science University, where he conducts his research and develops his inventions. His work is crucial in advancing the understanding and treatment of AML, contributing to the broader field of oncology.
Collaborations
Elie Traer collaborates with esteemed colleagues, including Jeffrey Tyner and Cristina Tognon. Their combined expertise enhances the research efforts and fosters innovation in the treatment of leukemia.
Conclusion
Elie Traer's contributions to the treatment of acute myeloid leukemia highlight his dedication to improving patient care through innovative methods. His work exemplifies the impact of research and invention in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile